Literature DB >> 4341500

Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.

D E Wilson, R S Lees.   

Abstract

The changes in other plasma lipoproteins which accompany alterations in very low density lipoproteins (VLDL) were studied in 31 normal and hyperlipidemic men and women who underwent weight reduction, carbohydrate induction, or clofibrate treatment. Plasma lipids and individual lipoprotein cholesterol concentrations were measured serially during control and treatment periods. Low density lipoprotein (LDL) protein was determined by radial immunodiffusion. Oppositely directed changes in VLDL and LDL were found with each of the three metabolic perturbations. Changes in high density lipoprotein (HDL) cholesterol generally paralleled those in LDL but were less consistent. Two patients with type III hyperlipoproteinemia failed to demonstrate reciprocal increases in LDL despite more than 40% reduction in plasma glycerides or VLDL with weight reduction or clofibrate therapy. After clofibrate therapy, LDL increased in proportion to the absolute decrease in VLDL cholesterol during treatment. LDL protein changed relatively less than did LDL cholesterol. The mechanism for the interdependency of plasma VLDL and LDL concentrations over the long term is not known and may be the result of altered rates of interconversion of these lipoproteins, or to feedback inhibition by VLDL of LDL production and release.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4341500      PMCID: PMC292233          DOI: 10.1172/JCI106896

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

Review 1.  Practical methods for plasma lipoprotein analysis.

Authors:  F T Hatch
Journal:  Adv Lipid Res       Date:  1968

2.  Treatment of hyperlipidemias.

Authors:  E H Strisower; G Adamson; B Strisower
Journal:  Am J Med       Date:  1968-10       Impact factor: 4.965

3.  Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment.

Authors:  L A Carlson; L Orö; J Ostman
Journal:  J Atheroscler Res       Date:  1968 Jul-Aug

4.  Functions and interrelationships of different classes of plasma lipoproteins.

Authors:  A V Nichols
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

Review 5.  Regulation of cholesterol metabolism. I.

Authors:  J M Dietschy; J D Wilson
Journal:  N Engl J Med       Date:  1970-05-14       Impact factor: 91.245

6.  The nature of pre beta (very low density) lipoproteins.

Authors:  R I Levy; R S Lees; D S Fredrickson
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

7.  An improved automated determination of serum total cholesterol with a single color reagent.

Authors:  W D Block; K J Jarrett; J B Levine
Journal:  Clin Chem       Date:  1966-10       Impact factor: 8.327

8.  Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia).

Authors:  W R Hazzard; D Porte; E L Bierman
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

9.  Immunoassay of plasma low-density lipoproteins.

Authors:  R S Lees
Journal:  Science       Date:  1970-07-31       Impact factor: 47.728

10.  Failure of bile acids to control hepatic cholesterogenesis: evidence for endogenous cholesterol feedback.

Authors:  H J Weis; J M Dietschy
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  36 in total

1.  HDL-cholesterol levels in the Multiple Risk Factor Intervention Trial (MRFIT) by the MRFIT Research Group 1,2.

Authors:  S Hulley; P Ashman; L Kuller; N Lasser; R Sherwin
Journal:  Lipids       Date:  1979-01       Impact factor: 1.880

2.  High-density lipoprotein in chronic renal failure and after renal transplantation.

Authors:  E Savdie; J C Gibson; J H Stewart; L A Simons
Journal:  Br Med J       Date:  1979-04-07

3.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

4.  [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].

Authors:  P Weisweiler; P Schwandt
Journal:  Klin Wochenschr       Date:  1977-08-15

5.  Effect of diet and exercise upon the cholesterol and triglyceride content of plasma lipoproteins in overweight children.

Authors:  K Widhalm; E Maxa; H Zyman
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

6.  Effect of polyenyl phosphatidyl choline on clofibrate-induced increase in LDL cholesterol.

Authors:  J Schneider; R Müller; W Buberl; H Kaffarnik; R Schubotz; L Hausmann; G Mühlfellner; O Mühlfellner
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

7.  Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men.

Authors:  M Stalder; D Pometta; A Suenram
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

8.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

Authors:  S Eisenberg; D Gavish; Y Oschry; M Fainaru; R J Deckelbaum
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.

Authors:  B Teng; G R Thompson; A D Sniderman; T M Forte; R M Krauss; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

10.  Characterization of plasma lipoproteins in swine with different propensities for obesity.

Authors:  T D Etherton; P M Kris-Etherton
Journal:  Lipids       Date:  1980-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.